Alternatives to Pairx
Pairx is a Drug Discovery tool: biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Drug Discovery companies to Pairx
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
- Website
Sinopia Biosciences54BiotechnologySan Diego, USA$2.2MBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
- Website
Isomorphic Labs68Drug DiscoveryLondon, United Kingdom$4.7BAI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.
- Website
WuXi AppTec66Drug DiscoveryShanghai, China$40.0MGlobal CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Adaptimmune Therapeutics44BiotechnologyAbingdon, United Kingdom$107.5MBiopharmaceutical company developing T-cell therapies for solid tumor cancers.
- Website
Sutro Biopharma40BiotechSouth San Francisco, United States$296.4MClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
- Website
Crown Bioscience54Drug DiscoverySan Diego, United States$262.4MA global contract research organization specializing in preclinical and translational oncology research.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Vividion Therapeutics22BiotechSan Diego, United States$267.0MBiopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Ella Therapeutics47Life SciencesBoston, United StatesDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Showing the 20 closest matches. See the rest on the Pairx profile.